Search - tctmd.com

Displaying 521 - 540 of 542

Sort: Relevancy | Date

News Conference News

PARTNER A: Transfemoral TAVR Improved QOL, Costs vs. Surgery

November 09, 2011

News Conference News

MUSTELA: Thrombectomy Use Not Associated with Smaller Infarcts at 1 Year

November 09, 2011

News Conference News

Mock Jury Votes on DAPT Duration: 12 Months Remains Best Option for Most Patients

November 08, 2011

News Conference News

Long-term Outcomes Improved with Biodegradable Biolimus-Eluting Stent vs. Permanent Polymer SES

November 08, 2011

News Conference News

EES Compared Favorably with SES In Two Pivotal Trials

November 08, 2011

News Conference News

Caution Urged in Widespread Adoption of TAVR

November 08, 2011

News Conference News

Ongoing Trials Explore Potential Benefits of Transradial PCI

November 08, 2011

News Conference News

Mitral, Aortic Regurgitation Increase Mortality After Transcatheter Valve Replacement

November 08, 2011

News Conference News

Coronary Heart Disease Mortality Down, But Prevention Efforts Still Needed

November 08, 2011

News Conference News

SAPPHIRE and CABANA Add More Validation for Carotid Artery Stenting

November 07, 2011

News Conference News

DES and Stent Thrombosis Revisited

November 07, 2011

News Conference News

Debate: PCI vs. CABG for Left Main Disease

November 07, 2011

News Conference News

TAVR: Incorporating Techniques into Daily Practice

November 07, 2011

News Conference News

Registry Studies Focus on Different TAVR Access Routes

November 07, 2011

News Conference News

Operator Learning Curve Important in CAS vs. CEA Outcomes

November 07, 2011

News Conference News

EES Associated with Reduced MACE Compared with SES

November 07, 2011

News Conference News

No Change Seen in European TAVR Clinical Use Patterns

November 06, 2011

News Conference News

Early Discontinuation of DAPT May Increase Risk of Stent Thrombosis

November 06, 2011

News Conference News

Prasugrel, Ticagrelor Reduced Incidence of Stent Thrombosis

November 06, 2011

Video

» Interview

PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk

November 4, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.